Literature DB >> 29457930

Nano-loaded human umbilical cord mesenchymal stem cells as targeted carriers of doxorubicin for breast cancer therapy.

Shunxiu Cao1, Jiamin Guo1, Yujing He2, Murad Alahdal1, Shanshan Tang1, Yuekui Zhao1, Zhaocong Yang1, Huashan Gao1, Wenjun Hu1, Hulin Jiang2, Lianju Qin3, Liang Jin1.   

Abstract

The main challenge of anticancer drugs is poor tumor targeting. Now cellular carriers are widely investigated to deliver anticancer agents. As an ideal cellular candidate, human umbilical cord derived mesenchymal stem cells (hUC-MSCs) possess inherent tropism potential to tumor. Here, we constructed hUC-MSCs carrying transferrin-inspired-nanoparticles that contain doxorubicin(hUC-MSCs-Tf-inspired-NPs) to achieve enhanced anti-tumor efficacy and made an evaluation. Results represented that hUC-MSCs-Tf-inspired-NPs not only exhibit the controlled-release property of Tf-inspired-NPs, but also integrate tumor tropism and penetrative abilities of MSCs. The tumor volume of nude mice bearing breast cancer MCF-7 treated with hUC-MSCs-Tf-inspired-NPs, was remarkably reduced compared to those treated with free drug or Tf-inspired-NPs. Thus, Tf-inspired-NPs loaded hUC-MSCs have a potential to deliver anticancer drugs.

Entities:  

Keywords:  doxorubicin; targeted delivery; Mesenchymal stem cells; artificial cells; breast cancer; nanoparticles

Mesh:

Substances:

Year:  2018        PMID: 29457930     DOI: 10.1080/21691401.2018.1434185

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  4 in total

Review 1.  Umbilical cord mesenchymal stem cells and breast cancer: a good therapeutic candidate or not? A minireview.

Authors:  Anahita Tavakoli; Mohammad Saeed Kahrizi; Kimia Safa; Reza ArefNezhad; Fatemeh Rezaei-Tazangi
Journal:  Mol Biol Rep       Date:  2022-08-08       Impact factor: 2.742

Review 2.  Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications.

Authors:  Carla Vicinanza; Elisabetta Lombardi; Francesco Da Ros; Miriam Marangon; Cristina Durante; Mario Mazzucato; Francesco Agostini
Journal:  World J Stem Cells       Date:  2022-01-26       Impact factor: 5.326

Review 3.  Application of Perinatal Derivatives on Oncological Preclinical Models: A Review of Animal Studies.

Authors:  Ricardo Teixo; Ana Salomé Pires; Eurico Pereira; Beatriz Serambeque; Inês Alexandra Marques; Mafalda Laranjo; Slavko Mojsilović; Roberto Gramignoli; Peter Ponsaerts; Andreina Schoeberlein; Maria Filomena Botelho
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

Review 4.  Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy.

Authors:  Ali Hassanzadeh; Amjad Hussein Altajer; Heshu Sulaiman Rahman; Marwan Mahmood Saleh; Dmitry O Bokov; Walid Kamal Abdelbasset; Faroogh Marofi; Majid Zamani; Yoda Yaghoubi; Mahboubeh Yazdanifar; Yashwant Pathak; Max Stanley Chartrand; Mostafa Jarahian
Journal:  Front Cell Dev Biol       Date:  2021-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.